1. Giacobini E.: Cholinesterase inhibitors: from the calabar bean to Alzheimer therapy. In: Giacobini E. (Ed.), Cholinesterase and cholinesterase inhibitors. From molecular biology to therapy. Martin Dunitz, London, pp. 181–222, 2000.
2. Davis K.L., Mohs R.C., Marin D.: Cholinergic markers in elderly patients with early signs of Alzheimer Disease. JAMA 281: 1401–1406, 1999.
3. Pappas B.A., Bayley P., Bui B.K., Hansen L.A., Thal L.J.: Choline acetyltransferase activity and cognitive domain scores of Alzheimer’s therapy. Neurobiol. Aging 21: 11–17, 2000.
4. Doody R.S., Pratt R.D., Perdomo C.A.: Clinical benefits of donepezil: results from a long-term Phase III extension trial. Neurology 52 (Suppl. 2): A174, 1999.
5. Mori F., Lai C.C., Fusi F., Giacobini E.: Cholinesterase inhibitors increase secretion of APPs in rat brain cortex. Neurol. Rep. 6: 633–636, 1995.